ShA9 killed S. aureus and inhibited PSMa expression in the mouse model. Meanwhile, ShA9 improved the disease severity, decreased the S. aureus burden with few adverse events in AD patients. The gene discussed is FOLH1; the disease is Alzheimer disease.